Viewing Study NCT06988618


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-03-09 @ 4:14 AM
Study NCT ID: NCT06988618
Status: RECRUITING
Last Update Posted: 2025-08-17
First Post: 2025-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Sponsor: Galderma R&D
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module